UBS expressed optimism about PVH (NYSE:PVH), stating that despite facing several macro challenges, the company has the potential to achieve long-term earnings growth due to its strong brand and healthy balance sheet. UBS has raised its price target for PVH from $92 to $115 and maintained its Buy rating.
The firm anticipates a 5-year EPS CAGR of over 15%, and credits CEO Stefan Larsson’s plan to enhance PVH’s profitability. The analyst suggests that PVH’s efforts to enhance its brands, product assortment, direct-to-consumer sales, inventory management, speed-to-market, and cost efficiencies are proving successful and could result in significantly higher financial benefits than previously anticipated.
At CWEB, we are always looking to expand our network of strategic investors and partners. If you're interested in exploring investment opportunities or discussing potential partnerships and serious inquiries. Contact: jacque@cweb.com